Cognitive Assessment: Clinical Trials

14 trials of Cognitive Assessment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated, 2 active not recruiting, 1 recruiting. 14 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Completed 8, Terminated 3, Active not recruiting 2, Recruiting 1
Phase 14Completed 2, Active not recruiting 1, Terminated 1
Phase 31Completed 1

Follow Cognitive Assessment: new trials by email Literature Review of Cognitive Assessment trials Research Report on Cognitive Assessment

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Cognitive Assessment, Obinutuzumab, Quality of Life Assessment - Primary Central Nervous System Lymphoma
Phase 2RecruitingProvidence Health & Services282024-03-132026-09-23
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
Memantine, Placebo, Cognitive Assessment - Glioma of Brain, Craniopharyngioma
Phase 2CompletedSt. Jude Children's Research Hospital412017-11-072026-06-23
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
Cognitive Assessment, Ipilimumab, Laboratory Biomarker Analysis - Metastatic Malignant Neoplasm in the Brain, Stage IV Non-Small Cell Lung Cancer AJCC v7
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center802016-12-162026-11-10
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
Cognitive Assessment, Palbociclib, Quality-of-Life Assessment - Breast Carcinoma Metastatic in the Brain, Estrogen Receptor Negative
Phase 2TerminatedNorthwestern University122016-08-312020-04-14
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma
Carboplatin, Cognitive Assessment, Cyclophosphamide - Desmoplastic/Nodular Medulloblastoma, Medulloblastoma
Phase 2CompletedChildren's Oncology Group262013-12-242023-01-09
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Cognitive Assessment, Gamma-Secretase Inhibitor RO4929097, Laboratory Biomarker Analysis - Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)52010-10-012024-11-19
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
3-Dimensional Conformal Radiation Therapy, Cognitive Assessment, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1252009-07-102022-08-04
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
bevacizumab, cetuximab, fluorouracil - Colorectal Cancer
Phase 2 / Phase 3CompletedMedical Research Council32402009-07-012013-12-19
Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Quality-of-Life Assessment, Questionnaire Administration, Placebo - Unspecified Adult Solid Tumor, Protocol Specific
Phase 2CompletedAbramson Cancer Center at Penn Medicine2262009-06-012020-04-09
Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
sunitinib malate, cognitive assessment - Cognitive/Functional Effects, Metastatic Cancer
Phase 2TerminatedCase Comprehensive Cancer Center142009-04-012014-09-29
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
paclitaxel albumin-stabilized nanoparticle formulation, pharmacological study, physiologic testing - Breast Cancer
Phase 2Active not recruitingCity of Hope Medical Center402008-02-112026-06-04
Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
AC regimen, cyclophosphamide, doxorubicin hydrochloride - Breast Cancer, Cognitive/Functional Effects
Phase 2CompletedUNICANCER402006-01-012013-09-04
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
irinotecan hydrochloride, cognitive assessment, management of therapy complications - Brain and Central Nervous System Tumors, Cognitive/Functional Effects
Phase 1 / Phase 2CompletedUniversity of California, Davis302002-12-012017-11-06
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
EGb761, donepezil hydrochloride, cognitive assessment - Brain and Central Nervous System Tumors, Radiation Toxicity
Phase 2CompletedWake Forest University Health Sciences682001-07-012021-09-09

Conditions studied

Brain Neoplasms (6)  ·  Breast Neoplasms (4)  ·  Breast Neoplasms, Male (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Central Nervous System Neoplasms (2)  ·  Craniopharyngioma (2)  ·  Ependymoma (2)  ·  Glioblastoma (2)  ·  Gliosarcoma (2)  ·  Medulloblastoma (2)  ·  Astrocytoma (1)  ·  Basal Cell Nevus Syndrome (1)  ·  Choroid Plexus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Case Comprehensive Cancer Center (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Medical Research Council (1)  ·  Northwestern University (1)  ·  Providence Health & Services (1)  ·  St. Jude Children's Research Hospital (1)  ·  UNICANCER (1)  ·  University of California, Davis (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (12)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Puerto Rico (1)  ·  United Kingdom (1)

Top investigators

Allan Y. Chen, MD, PhD (1)  ·  Cristofanilli Massimo, MD (1)  ·  David M. Peereboom, MD (1)  ·  E. G. C. Brain, MD, PhD (1)  ·  Edward G. Shaw, MD (1)  ·  Evanthia Galanis (1)  ·  Heather M. Conklin, PhD (1)  ·  Jing Li (1)  ·  Lucie E Lafay-Cousin (1)  ·  Michael Perlis, MD (1)  ·  Mina Sedrak, MD (1)  ·  Morris D Groves (1)  ·  Prakash Ambady, MD (1)  ·  Timothy Maughan, MD (1)

Results publications

PMID 16549835, PMID 25492923, PMID 31386061, PMID 41170811

NIH funding

N01CM00039 (1), P30CA016672 (1), P30CA033572 (1), P30CA043703 (1), P30CA060553 (1), R21CA218625 (1), U01CA062461 (1), U01CA069852 (1), U01CA076576 (1), U10CA025224 (1), U10CA081851 (1), U10CA098543 (1), U10CA180821 (1), U10CA180886 (1)